Baricit 2 mg tablet is a Janus kinase (JAK) inhibitor used for adults with moderately to severely active rheumatoid arthritis after other treatments have not worked well enough. It is an immunosuppressant medicine that helps control joint inflammation.
There are 14 brands of Baricitinib listed in Bangladesh. By unit price, Baricit is among the cheapest of them.
What is Baricit 2 mg Tablet?
Baricit 2 mg tablet contains baricitinib, a Janus kinase (JAK) inhibitor. It is an immunosuppressant that works by blocking certain signals inside immune cells that drive inflammation. It is prescribed for adults with moderately to severely active rheumatoid arthritis who have not responded adequately to one or more TNF antagonist therapies. Baricitinib may be used alone or with methotrexate or other disease-modifying antirheumatic drugs. Because it affects the immune system, regular blood tests may be needed and doctors assess each patient carefully before and during treatment.
Uses of Baricit
Baricit 2 mg tablet is used to treat moderately to severely active rheumatoid arthritis in adults who have had an inadequate response to one or more TNF antagonist therapies. It helps reduce inflammation and joint symptoms associated with this condition. The medicine is taken by mouth. It may be prescribed alone or in combination with methotrexate or other disease-modifying antirheumatic drugs. It is not meant for everyone; a doctor decides whether it is suitable based on the person's condition and history.
How to use Baricit
Baricit 2 mg tablet is taken by mouth. The doctor decides the dose and how long you take it, including any change if you also take certain other medicines. Swallow the tablet as directed by your doctor. Do not start, stop or change the medicine on your own. If you miss a dose, ask your doctor or pharmacist what to do. Regular follow-up and blood tests may be arranged by your doctor to check your response and monitor for unwanted effects.
Side effects of Baricit
Like all medicines, Baricit 2 mg tablet can cause side effects. Because it affects the immune system, serious infections may occur; tell your doctor if you develop fever, cough, or other signs of infection. Other possible problems include blood clots, tears in the stomach or bowel wall, and changes in blood counts or liver tests. Your doctor may check your blood regularly. Seek medical help if you notice unusual symptoms. The doctor or pharmacist can explain what to watch for.
Safety and precautions
Baricit 2 mg tablet is not suitable for everyone. It should not be started if you have an active serious infection, including active tuberculosis, or certain low blood counts. It is not known whether baricitinib harms an unborn baby, and women are advised not to breastfeed while taking it. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Caution is needed if you are at risk of blood clots or gastrointestinal perforation. Live vaccines should be avoided during treatment. Your doctor will decide if this medicine is appropriate for you.
Frequently asked questions
What is Baricit 2 mg tablet used for and what kind of medicine is it?
It is used for adults with moderately to severely active rheumatoid arthritis who have not responded well to one or more TNF antagonist therapies. It is a Janus kinase (JAK) inhibitor, an immunosuppressant that helps reduce inflammation. It may be used alone or with other disease-modifying antirheumatic drugs. Your doctor will decide if it is right for you.
Which medicines may interact with Baricit 2 mg tablet?
Baricitinib may interact with strong OAT3 inhibitors such as probenecid, and the doctor may need to adjust the dose. It should not be combined with other JAK inhibitors or biologic DMARDs. Live vaccines should be avoided. Tell your doctor or pharmacist about all medicines, supplements and vaccines you take before starting treatment.
What side effects should I watch for and when should I call the doctor?
Watch for signs of infection such as fever or cough, and for symptoms that could suggest blood clots or stomach or bowel problems. Changes in blood counts or liver tests can occur and are checked by blood tests. Call your doctor promptly if you feel unwell or notice unusual symptoms. Do not stop the medicine without medical advice.
Baricitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
Limitation of Use: Use of Baricitinib in combination with other ... Read moreBaricitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more TNF antagonist therapies.
Limitation of Use: Use of Baricitinib in combination with other JAK inhibitors, biologic DMARDs or with potent immunosuppressants such as Azathioprine and cyclosporine is not recommended.
Pharmacology
Baricitinib is a Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoiesis and immune cell function. Within the signaling pathway, JAKs phosphorylate and activate Signal Transducers and Activators of Transcription (STATs) which modulate intracellular activity including gene expression. Baricitinib modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs.
Dosage & Administration
The recommended dose of Baricitinib is 2 mg once daily. Baricitinib may be used as monotherapy or in combination with Methotrexate or other DMARDs.
Interaction
The recommended dose of Baricitinib in patients taking strong Organic Anion Transporter 3 (OAT3) inhibitors (e.g., probenecid) is 1 mg once daily
Contraindications
Anemia: Avoid initiation or interrupt Baricitinib in patients with hemoglobin less than 8 g/dL.
Lymphopenia: Avoid initiation or interrupt Baricitinib in patients with an Absolute Lymphocyte Count less than 500 cells/mm3.
Neutropenia: Avoid initiation or interrupt Baricitinib in patients with an Absolute Neutrophil Count less than 1000 cells/mm3.
Side Effects
It is not known if Baricitinib will harm an unborn baby. Because of the potential for serious adverse reactions in nursing infants, advice an Baricitinib treated woman not to breastfeed.
Pregnancy & Lactation
It is not known if Baricitinib will harm an unborn baby. Because of the potential for serious adverse reactions in nursing infants, advice an Baricitinib treated woman not to breastfeed.
Precautions & Warnings
Serious Infections: Avoid use of Baricitinib in patients with active, serious infection, including localized infections. If a serious infection develops, interrupt Baricitinib therapy until the infection is controlled. Do not give Baricitinib to patients with active tuberculosis.
Thrombosis: Use with caution in patients who may be at increased risk.
Gastrointestinal Perforations: Use with caution in patients who may be at increased risk.
Laboratory Assessment: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes, and lipids.
Vaccinations: Avoid use of Baricitinib with live vaccines
Overdose Effects
In case of an overdose, it is recommended that the patient should be monitored for signs and symptoms of adverse reactions. Patients who develop adverse reactions should receive appropriate treatment.
Storage Conditions
Store below 30°C. Protect from light & moisture. Keep all medicines out of the reach of children.
Alternative brands of Baricitinib
Other brands with the same generic name, cheapest first.